EVALUATION OF THE FIBRINOLYTIC STATE AFTER ADMINISTRATION OF UROKINASE.
D000818:Animals; D001826:Body Fluids; D003850:Deoxyribonuclease I; D004285:Dogs; D005342:Fibrinolysis; D007793:Lagomorpha; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013552:Swine; D013917:Thrombin; D015912:Thrombolytic Therapy; D014556:Urine; D014568:Urokinase-Type Plasminogen Activator
D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D013917:Thrombin; D014568:Urokinase-Type Plasminogen Activator
DOGS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIS; PHARMACOLOGY; RABBITS; STREPTODORNASE AND STREPTOKINASE; SWINE; THROMBIN; URINE